4 unknown, 2 completed, 2 terminated, 2 withdrawn. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Unknown 4, Completed 2, Terminated 2, Withdrawn 2, Not yet recruiting 1 |
Follow IVIg: new trials by email Literature Review of IVIg trials Research Report on IVIg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia methotrexate, rituximab, bortezomib - Hypophosphatasia | Phase 4 | Withdrawn | Alexion Pharmaceuticals, Inc. | 2026-07-29 | 2025-12-18 | |
| Non Inferiority KawasakI Trial With Anakinra Anakinra, Intravenous Immunoglobulins, Human - Kawasaki Disease, Anakinra | Phase 4 | Withdrawn | Meyer Children's Hospital IRCCS | 2026-04-01 | 2026-10-26 | |
| IVIG in Painful Sensory Neuropathy Intravenous immunoglobulin, Placebo - Sensory Neuropathy, Small Fiber Neuropathy | Phase 4 | Not yet recruiting | Sorlandet Hospital HF | 20 | 2024-02-01 | 2023-12-27 |
| Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections IVIG - Viremia, Bacteremia | Phase 4 | Unknown | Shanghai Changzheng Hospital | 40 | 2023-04-01 | 2023-04-05 |
| IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation IVIG - Covid19, SARS-CoV Infection | Phase 4 | Unknown | Sharp HealthCare | 10 | 2020-11-01 | 2020-11-04 |
| Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 Octagam - Sars-CoV2 | Phase 4 | Completed | George Sakoulas, MD | 34 | 2020-04-28 | 2021-06-25 |
| A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) IVIG - Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections | Phase 4 | Unknown | IMMUNOe Research Centers | 21 | 2017-11-24 | 2019-11-19 |
| Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody IVIG, Prednisolone - Epilepsy, Unspecified, Intractable | Phase 4 | Unknown | Seoul National University Hospital | 40 | 2015-09-01 | 2016-03-01 |
| A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy Intravenous Immunoglobulin, Placebo - HIV-associated Myelopathy | Phase 4 | Terminated | David M. Simpson | 12 | 2012-02-01 | 2018-04-13 |
| Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis IVIG, PLEX - Myasthenia Gravid | Phase 4 | Completed | University Health Network, Toronto | 87 | 2007-03-01 | 2010-08-11 |
| IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff intravenous immunoglobulin G (IVIG), Placebo - Clostridium Difficile-associated Diarrhea (CDAD) | Phase 4 | Terminated | University of Pittsburgh | 14 | 2003-10-01 | 2016-10-25 |
COVID-19 (2) · Anxiety Disorders (1) · Bacteremia (1) · Coronavirus Infections (1) · Epilepsy (1) · Hypophosphatasia (1) · Mucocutaneous Lymph Node Syndrome (1) · Myasthenia Gravis (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Obsessive-Compulsive Disorder (1) · Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (1) · Pediatric acute-onset neuropsychiatric syndrome (1) · Peripheral Nervous System Diseases (1) · Polyneuropathies (1)
Alexion Pharmaceuticals, Inc. (1) · David M. Simpson (1) · George Sakoulas, MD (1) · IMMUNOe Research Centers (1) · Meyer Children's Hospital IRCCS (1) · Seoul National University Hospital (1) · Shanghai Changzheng Hospital (1) · Sharp HealthCare (1) · Sorlandet Hospital HF (1) · University Health Network, Toronto (1) · University of Pittsburgh (1)
United States (5) · Canada (1) · South Korea (1)
George Sakoulas, MD (2) · David Barth, MD (1) · David Simpson, MD (1) · Gabriele Simonini, Prof (1) · George L Arnold, MD (1) · Isaac Melamed, MD (1) · Sang Kun Lee, Professor (1) · Vera Bril, BSc, MD, FRCPC (1)